Paper7600564
Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
Lasek W and 7 others. Cancer Immunol Immunother, 1995. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice. Papers, record 7600564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7600564
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunologic Factors | Major topic |
| Interferon-gamma | Major topic |
| Macrophage Colony-Stimulating Factor | Major topic |
| Melanoma, Experimental | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Animals | |
| Bone Marrow | |
| Disease Progression | |
| Drug Screening Assays, Antitumor | |
| Drug Synergism | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Monocytes | |
| Recombinant Proteins |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,497,112 | Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice. | Int J Cancer | 1987 | https://conductscience.org/library/papers/3497112 | PubMed |
| 2 | 3,095,251 | In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. | Int J Cancer | 1986 | https://conductscience.org/library/papers/3095251 | PubMed |
| 3 | 3,121,728 | Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages. | J Immunol | 1987 | https://conductscience.org/library/papers/3121728 | PubMed |
| 4 | 8,394,092 | Macrophage activation by T cells: cognate and non-cognate signals. | Curr Opin Immunol | 1993 | https://conductscience.org/library/papers/8394092 | PubMed |
| 5 | 8,033,141 | Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. | Cancer Res | 1994 | https://conductscience.org/library/papers/8033141 | PubMed |
| 6 | 3,089,802 | Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines. | Eur J Cancer Clin Oncol | 1986 | https://conductscience.org/library/papers/3089802 | PubMed |
| 7 | 2,021,943 | Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice. | Cancer Res | 1991 | https://conductscience.org/library/papers/2021943 | PubMed |
| 8 | 3,053,899 | The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. | J Immunol | 1988 | https://conductscience.org/library/papers/3053899 | PubMed |
| 9 | 8,196,902 | Macrophage colony-stimulating factor for cancer therapy. | Oncology | 1994 | https://conductscience.org/library/papers/8196902 | PubMed |
| 10 | 8,276,722 | Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor. | Jpn J Cancer Res | 1993 | https://conductscience.org/library/papers/8276722 | PubMed |
| 11 | 8,196,898 | Tumor necrosis factor for the treatment of malignancies. | Oncology | 1994 | https://conductscience.org/library/papers/8196898 | PubMed |
| 12 | 8,505,145 | Effect of interferon-gamma, tumor necrosis factor, interleukin-1 and interleukin-6 on the modulation of anti-tumor responses of bone marrow derived macrophages. | Int J Immunopharmacol | 1993 | https://conductscience.org/library/papers/8505145 | PubMed |
| 13 | 8,293,417 | Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. | Cancer | 1994 | https://conductscience.org/library/papers/8293417 | PubMed |
| 14 | 1,985,870 | Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells. | Int J Cancer | 1991 | https://conductscience.org/library/papers/1985870 | PubMed |
| 15 | 8,345,197 | Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. | J Immunol | 1993 | https://conductscience.org/library/papers/8345197 | PubMed |
| 16 | 2,428,865 | Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. | J Immunol | 1986 | https://conductscience.org/library/papers/2428865 | PubMed |
| 17 | 3,053,901 | Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. | J Immunol | 1988 | https://conductscience.org/library/papers/3053901 | PubMed |
| 18 | 3,131,832 | Therapeutic potential of cytokines: a comparison of preclinical and clinical studies. | Prog Exp Tumor Res | 1988 | https://conductscience.org/library/papers/3131832 | PubMed |
| 19 | 6,982,897 | Structure-function studies of a colony stimulating factor (CSF-1). | J Biol Chem | 1982 | https://conductscience.org/library/papers/6982897 | PubMed |
| 20 | 8,419,170 | Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. | Eur J Immunol | 1993 | https://conductscience.org/library/papers/8419170 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,293,965 | The Melding of Drug Screening Platforms for Melanoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31293965 | PubMed |
| 19,399,188 | A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agent. | PLoS One | 2009 | https://conductscience.org/library/papers/19399188 | PubMed |
| 18,947,424 | The prince and the pauper. A tale of anticancer targeted agents. | Mol Cancer | 2008 | https://conductscience.org/library/papers/18947424 | PubMed |
| 18,472,817 | Cancer immunotherapy: potential involvement of mediators. | Mediators Inflamm | 1997 | https://conductscience.org/library/papers/18472817 | PubMed |
| 16,709,225 | Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity. | Int J Exp Pathol | 2006 | https://conductscience.org/library/papers/16709225 | PubMed |
| 10,982,366 | Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. | J Virol | 2000 | https://conductscience.org/library/papers/10982366 | PubMed |
| 8,957,067 | In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-alpha against tumor necrosis factor-resistant tumors. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8957067 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF1 | 1,435 | PubTator's text mining | https://conductscience.org/library/genes/1435 | NCBI Gene |
| TNF | 7,124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7600564
GET https://conductscience.org/api/papers/v1/7600564/references?page=2